ZRANB2 and hepatocellular carcinoma: ZRANB2 knockdown reduced number of colonies and increased number of TUNEL-positive cells (Figures 5(b) and 5(c)), which suggested that ZRANB2 acted as an oncogene in hepatocellular carcinoma.